Condition: Thrombosis, Deep Vein · Iliofemoral; Thrombosis · Sponsor: Mercator MedSystems, Inc.
This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamethasone sodium phosphate injection) around the deep veins after DVT recanalization, where DVT symptoms were present for up to 14 days prior to recanalization. The goal of the study is to see if local anti-inflammation helps prevent re-thrombosis of the blood vessel and improvement in symptoms for up to 24 months after the initial DVT recanalization procedure.
This description comes directly from the study's public registry record.
Kirk Seward, PhD · 510-614-4550 · kseward@mercatormed.com
Always discuss trial participation with your own doctor first.
| Providence St. Joseph Hospital | Orange, California, United States | Recruiting |
| Vascular Care Connecticut | Darien, Connecticut, United States | Recruiting |
| HCA Florida JFK Hospital | Atlantis, Florida, United States | Recruiting |
| Baptist Health | Jacksonville, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| CIS Clinical Research | Houma, Louisiana, United States | Recruiting |
| Medstar Health Research Institute | Hyattsville, Maryland, United States | Recruiting |
| Englewood Health | Englewood, New Jersey, United States | Recruiting |
| Stony Brook University Hospital | Stony Brook, New York, United States | Recruiting |
| NC Heart and Vascular Research | Raleigh, North Carolina, United States | Recruiting |
| OhioHealth Research Institute | Columbus, Ohio, United States | Active Not Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04862468